wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26745948-06DFD29B-B5E8-4A40-92F8-68745B236EB1
Q26745948-06DFD29B-B5E8-4A40-92F8-68745B236EB1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26745948-06DFD29B-B5E8-4A40-92F8-68745B236EB1
New drugs in prostate cancer
P2860
Q26745948-06DFD29B-B5E8-4A40-92F8-68745B236EB1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26745948-06DFD29B-B5E8-4A40-92F8-68745B236EB1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8f0d18e1b9fecd091e6917aa71cec22747ec793e
P2860
Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial.